| Pluripotent Stem Cells Research | Lifetime | 7 | JP 1 | 99.91 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 9 | JP 1 | 99.90 |
| MicroRNA in disease regulation | Lifetime | 67 | JP 2 | 99.62 |
| Nerve injury and regeneration | Lifetime | 23 | JP 1 | 99.71 |
| Mesenchymal stem cell research | Lifetime | 42 | JP 3 | 99.63 |
| RNA Research and Splicing | Lifetime | 67 | JP 1 | 99.63 |
| CRISPR and Genetic Engineering | Lifetime | 62 | JP 1 | 99.67 |
| Cancer-related molecular mechanisms research | Lifetime | 214 | JP 10 | 99.11 |
| Biomedical Ethics and Regulation | Lifetime | 21 | JP 1 | 98.39 |
| RNA regulation and disease | Lifetime | 123 | JP 9 | 98.54 |
| Spinal Cord Injury Research | Lifetime | 77 | JP 2 | 98.83 |
| Epigenetics and DNA Methylation | Lifetime | 668 | JP 33 | 98.43 |
| Nuclear Receptors and Signaling | Lifetime | 83 | JP 4 | 98.63 |
| Developmental Biology and Gene Regulation | Lifetime | 91 | JP 4 | 98.83 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 414 | JP 15 | 98.60 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 368 | JP 19 | 97.94 |
| Signaling Pathways in Disease | Lifetime | 229 | JP 18 | 97.41 |
| Spaceflight effects on biology | Lifetime | 235 | JP 11 | 97.16 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 247 | JP 19 | 97.23 |
| Axon Guidance and Neuronal Signaling | Lifetime | 181 | JP 10 | 97.24 |
| Cancer Cells and Metastasis | Lifetime | 997 | JP 62 | 96.32 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 420 | JP 18 | 96.31 |
| Neurobiology and Insect Physiology Research | Lifetime | 890 | JP 46 | 96.31 |
| Electromagnetic Fields and Biological Effects | Lifetime | 161 | JP 9 | 95.86 |
| Congenital heart defects research | Lifetime | 651 | JP 41 | 95.56 |
| Genetics, Aging, and Longevity in Model Organisms | Lifetime | 498 | JP 21 | 95.33 |
| Animal Genetics and Reproduction | Lifetime | 899 | JP 71 | 95.14 |
| Macrophage Migration Inhibitory Factor | Lifetime | 207 | JP 8 | 93.36 |
| Hedgehog Signaling Pathway Studies | Lifetime | 743 | JP 48 | 91.91 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 938 | JP 94 | 91.89 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 657 | JP 50 | 90.07 |
| Spinal Dysraphism and Malformations | Lifetime | 738 | JP 47 | 90.88 |
| Pluripotent Stem Cells Research | 2021-2025 | 2 | JP 1 | 99.69 |
| Nerve injury and regeneration | 2021-2025 | 8 | JP 1 | 98.47 |
| Nuclear Receptors and Signaling | 2021-2025 | 4 | JP 1 | 96.90 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 17 | JP 1 | 97.81 |
| Mesenchymal stem cell research | 2021-2025 | 58 | JP 2 | 96.75 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 58 | JP 1 | 97.30 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 79 | JP 1 | 96.96 |
| Spinal Cord Injury Research | 2021-2025 | 70 | JP 2 | 95.11 |
| Biomedical Ethics and Regulation | 2021-2025 | 40 | JP 2 | 92.95 |
| CRISPR and Genetic Engineering | 2021-2025 | 637 | JP 18 | 90.99 |
| RNA Research and Splicing | 2021-2025 | 667 | JP 25 | 89.65 |
| Tissue Engineering and Regenerative Medicine | 2021-2025 | 727 | JP 36 | 83.30 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 712 | JP 37 | 82.96 |
| Hearing, Cochlea, Tinnitus, Genetics | 2021-2025 | 825 | JP 25 | 82.27 |
| Developmental Biology and Gene Regulation | 2021-2025 | 165 | JP 13 | 70.74 |
| Animal Genetics and Reproduction | 2021-2025 | 778 | JP 49 | 66.50 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 847 | JP 44 | 50.38 |
| Bone and Dental Protein Studies | 2021-2025 | 766 | JP 38 | 50.66 |
| Electromagnetic Fields and Biological Effects | 2021-2025 | 927 | JP 39 | 36.90 |